Caricamento...
Acute myeloid leukemia: current progress and future directions
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The manage...
Salvato in:
| Pubblicato in: | Blood Cancer J |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900255/ https://ncbi.nlm.nih.gov/pubmed/33619261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00425-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|